Table 2.

Crude incidence rates of 12 CVDs with 95% CIs in individuals with and without PMR and GCA

	Coronary and CVD death composite		Fatal and non-fatal cardiovascular composite
	No. Events	Rate per 1000 PY (95% CI)	No. events	Rate per 1000 PY (95% CI)
PMR only	1075	23.95 (22.56 to 25.43)	2457	54.74 (52.62 to 56.95)
GCA only	148	30.44 (25.91 to 35.76)	387	79.60 (72.05 to 87.94)
All GCA	216	25.32 (22.16 to 28.93)	555	65.06 (59.86 to 70.70)
PMR and/or GCA	1291	24.17 (22.89 to 25.52)	3012	56.39 (54.41 to 58.44)
Free of PMR and GCA	10 826	25.80 (25.32 to 26.29)	24 372	58.08 (57.36 to 58.82)

Notes: non-disease estimates are obtained in up to 10 randomly selected patients without PMR or GCA matched for sex, age, medical practice and index date; PY rates are unadjusted; PMR and GCA estimates are obtained among patients diagnosed with these diseases who had supporting information for disease diagnosis. The coronary and CVD death composite endpoint includes: stable angina, myocardial infarction, coronary heart diseases not otherwise specified and any cardiovascular death. The fatal and non-fatal CVD composite endpoint additionally includes: transient ischaemic attack, peripheral arterial disease and non-fatal heart failure and ischaemic or haemorrhagic stroke.

CVD, cardiovascular disease; GCA, giant cell arteritis; PMR, polymyalgia rheumatica; PY, patient-years of follow-up.